HER2 as a therapeutic target for CAR T-cell therapy: biological basis, clinical progress, challenges, and future perspectives

Vaibhav Soni, Suryapriya B., Khushi Rode, Priti Paul, Rahul Nair, Bharath M, Anish Dhuri, Tanmoy Kanp, Anamika Sharma, Pankaj Kumar Singh
International Journal of Pharmaceutics · Elsevier · 2027-01-01 · DOI: 10.1016/j.ijpharm.2026.127690

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles